
-
Chile ups hake catch limits for small-scale fishermen
-
Taiwan pursues homegrown Chinese spies as Beijing's influence grows
-
Myanmar's Aung San Suu Kyi marks 80th in junta jail
-
Hurricane Erick strengthens as it barrels toward Mexico
-
Thai PM faces growing calls to quit in Cambodia phone row
-
Justice at stake as generative AI enters the courtroom
-
Donnarumma warns PSG 'hungry' for more success at Club World Cup
-
From Tehran to Toronto via Turkey: an Iranian's bid to flee war
-
Bolivia risks debt default without new funding: president to AFP
-
Messi fit to face Porto: Inter Miami's Mascherano
-
Waymo looks to test its self-driving cars in New York
-
Lakers to be sold in record-breaking $10 billion deal: ESPN
-
Real Madrid held by Al-Hilal after Man City win Club World Cup opener
-
Warning signs on climate flashing bright red: top scientists
-
Real Madrid held by Al-Hilal in Alsonso's debut
-
Korda 'hungry' for Women's PGA after US Open heartbreak
-
US stocks flat as Fed keeps rates steady, oil prices gyrate
-
US to screen social media of foreign students for anti-American content
-
'Argentina with Cristina': Thousands rally for convicted ex-president
-
Guardiola hails new signings as Man City survive 'tough conditions'
-
Gaza rescuers say 33 killed by Israel fire
-
US approves Gilead's twice-yearly injection to prevent HIV
-
Khamenei vows Iran will never surrender, hypersonic missiles target Israel
-
Brazil says free of bird flu, will resume poultry exports
-
Lions boss Farrell says Test places still up for grabs
-
Climate change could cut crop yields up to a quarter
-
Hurricane Erick strengthens on approach to Mexico's Pacific coast
-
US Fed keeps interest rates unchanged in face of Trump criticism
-
South Africa captain Bavuma hails special Test triumph
-
Man City ease into Club World Cup campaign with win against Wydad
-
Pacers sweating on Haliburton injury ahead of NBA Finals clash
-
'Terrified': Supporters fear for prisoners trapped in Iran
-
South Africa moves closer to hosting Formula One race
-
Chelsea's Mudryk charged over anti-doping violation
-
Draper survives scare to reach Queen's quarter-finals
-
Pant hopes India can make country 'happy again' after plane crash
-
US Supreme Court upholds ban on gender-affirming care for minors
-
UK risks more extreme, prolonged heatwaves in future: study
-
Gosdens celebrate Royal Ascot double as Buick motors home on Ombudsman
-
Oil prices drop following Trump's Iran comments, US stocks rise
-
Musk's X sues to block New York social media transparency law
-
Iran-Israel war: a lifeline for Netanyahu?
-
Gaza Humanitarian Foundation initiative 'outrageous': UN probe chief
-
India's Pant glad of Anderson and Broad exits ahead of England Tests
-
Moth uses stars to navigate long distances, scientists discover
-
Hurricane Erick approaches Mexico's Pacific coast
-
Gaza flotilla skipper vows to return
-
Netherlands returns over 100 Benin Bronzes looted from Nigeria
-
Nippon, US Steel say they have completed partnership deal
-
Almeida takes fourth stage of Tour of Switzerland with injured Thomas out

Japan drugmaker reports two more deaths in supplement scare
A Japanese drugmaker whose dietary supplements are at the centre of a growing health scare reported on Thursday two more deaths potentially related to its tablets.
Last week, Kobayashi Pharmaceutical recalled three supplement brands -- "Beni Koji Choleste Help" and two others -- after customer complaints of kidney problems.
The over-the-counter products contain an ingredient called red yeast rice, or "beni koji", which is supposed to help lower cholesterol.
Thursday's announcement brings the total number of deaths under investigation by the company and health ministry to four, with more than 100 other people hospitalised.
"We were told yesterday by a bereaved family that a person who had been using Choleste Help had passed away due to kidney disease," the drugmaker said in a statement.
It added it had been told separately that another person who had used Choleste Help in recent years had died.
"We are in the process of confirming the facts and causal relationships in both of these cases," the statement said.
"However, we decided to make this report public from the viewpoint of prompt disclosure."
Medical studies describe red yeast rice as an alternative to statins for lowering high cholesterol, but also warn of a risk of organ damage depending on its chemical make-up.
Kobayashi Pharmaceutical sells a wide range of health products marketed through television adverts in Japan.
The Osaka-based company says it has also supplied red yeast rice to around 50 other firms in Japan and two in Taiwan.
Government spokesman Yoshimasa Hayashi said Thursday that authorities were doing "their utmost to ensure food safety, including identifying the substance that caused the health harm and how it became present in the product".
The government has ordered various health-food makers to review their products, while informing foreign countries about the issue through Japan's embassies, he said.
Dozens of Japanese firms that used beni koji provided by Kobayashi Pharmaceutical have also separately announced recalls.
The affected products include health tablets as well as a rose-coloured sparkling sake, salad dressing, bread and miso paste used in many traditional dishes.
Kobayashi Pharmaceutical has said analysis had found a possibility that the products contained "ingredients we had not intended to include".
But it said it did not find any citrinin produced by red yeast rice, which is toxic and can damage the kidneys.
R.Flueckiger--VB